Frank X. Leonard, President, CNS Cancers US at NovoCure Ltd (NVCR), sold 5,806 shares at $77.64 ($447K) on 2023-03-03, disclosed to the SEC on 2023-03-06.
Open-market sale of $447k NVCR by President, CNS Cancers US. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.28 | 844 | $64K | 14.2% |
| 2 | $75.28 | 844 | $64K | 14.2% |
| 3 | $77.64 | 2,059 | $160K | 35.8% |
| 4 | $77.64 | 2,059 | $160K | 35.8% |
| Total | $76.95 avg | 5,806 | $447K | 100% |
| Filing → |
| NVCR | SELL | 2026-03-03 | $231K | — | Filing → |
| NVCR | SELL | 2025-06-04 | $1.0M | — | Filing → |
| NVCR | SELL | 2025-03-04 | $47K | — | Filing → |